Growth Inhibition of Hepatocarcinoma in Nude Mice by Adenovirus-Mediated Transfer of Thymidine Kinase Gene Driven by IGF-H P3 Promoter

周鸿科,杨冬华,汤绍辉,黄卫,江向武
DOI: https://doi.org/10.3969/j.issn.1000-8179.2010.12.001
2010-01-01
Chinese Journal of Clinical Oncology
Abstract:Objective: To observe the effects of adenovirus-mediated transfer of thymidine kinase gene driven by IGF-II P3 promoter and GCV system on the growth of xenografted hepatocellular carcinoma in nude mice. Methods: HepG2 cells were inoculated into nude mice to establish transplantation tumors. Ad-tkEGFP-P3 was intratumorously injected and GCV was intraperitoneally injected the next day. Tumor sizes were measured every 4 days. The nude mice were euthanized and tumors were removed on the last day. Tumor size was then measured. RT-PCR was performed to detect the tk mRNA expression in tumor, heart, liver and kidney tissue. The toxic effect was estimated by H&E staining and pathological tests on the heart, liver and kidneys. Results: The inhibition of tumor growth in group Ad-tkEGFP-P3+GCV nude mice was more significant compared with the other 3 groups (P<0.05). The tumor volumes in group Ad-tkEGFP-P3 + GCV nude mice were smaller than those of the other 3 groups. Tk mRNA could only be detected in tumor tissue, but not in heart, liver or kidney tissue. No inflammation, degeneration, necrosis nor apoptosis was observed in the heart, liver and kidneys. Conclusion: Intratumor injection of Ad-tkEGFP-P3 following GCV intraperitoneal injection could inhibit the growth of transplantation tumors in nude mice. There is no obvious toxic effect of Ad-tkEGFP-P3 following GCV treatment on nude mice.
What problem does this paper attempt to address?